Bright.md has raised $16.7 million in its oversubscribed Series C round co-led by B Capital, Seven Peaks Ventures and Concord Health Partners.
Editor’s Note: This publication originally appeared on Bright.md’s website.
Bright.md will use the funding for accelerated market and technology expansion of its suite of care-automation solutions, including their award-winning flagship product, SmartExam™, a capacity-boosting, AI-powered, asynchronous telehealth platform already deployed in leading hospitals and healthcare systems across the U.S. and Canada.
